Literature DB >> 2008443

Peripheral insulin insensitivity in the hyperglycemic athymic nude mouse: similarity to noninsulin-dependent diabetes mellitus.

A Zeidler1, N S Shargill, T M Chan.   

Abstract

Previous studies in the homozygous athymic nude mouse (USC colony) have indicated a diabetic state characterized by spontaneous hyperglycemia, abnormal glucose tolerance, and normal or relatively decreased plasma insulin levels. Pancreatic islet cell population assessed by morphometric and immunohistochemical studies demonstrated normal insulin-secreting cells in the hyperglycemic nude mouse. To further elucidate the pathogenesis of the hyperglycemic state in the athymic nude mouse, we have studied the effects of insulin on the transport of glucose in skeletal muscle by measuring basal and insulin-stimulated uptake of a nonmetabolizable glucose analogue, 2-deoxy-D-glucose by using the perfused hindquarter preparation. Although basal 2-deoxy-D-glucose uptake by peripheral skeletal muscle was similar in the hyperglycemic and control mice, the insulin-stimulated uptake of 2-deoxy-D-glucose was significantly decreased in the athymic nude mouse at both 0.1 milliunits/ml and supraphysiologic concentrations of insulin (1 milliunit/ml) when compared with control mice (P less than 0.05 and P less than 0.001, respectively). This form of peripheral insulin insensitivity with normal pancreatic beta cell reserve, in addition to the lean body mass of the diabetic animal, mimics in part the peripheral insulin insensitivity seen in non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008443     DOI: 10.3181/00379727-196-43216

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  7 in total

1.  Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.

Authors:  Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2010-05-10

2.  Partial prevention of hepatic lipid alterations in nude mice by neonatal thymulin gene therapy.

Authors:  Margarita M García de Bravo; Mónica P Polo; Paula C Reggiani; Omar J Rimoldi; Mireille Dardenne; Rodolfo G Goya
Journal:  Lipids       Date:  2006-08       Impact factor: 1.880

Review 3.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

4.  Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.

Authors:  Marc Throsby; Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-08-10

5.  Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice.

Authors:  Gamal Badr; Mohamed Mohany; Ali Metwalli
Journal:  Lipids Health Dis       Date:  2011-11-09       Impact factor: 3.876

6.  Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress.

Authors:  Ahmad A Al Ghamdi; Gamal Badr; Wael N Hozzein; Ahmed Allam; Noori S Al-Waili; Mohammed A Al-Wadaan; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-09-15       Impact factor: 3.615

7.  Sex- and Dose-Specific Effects of Maternal Bisphenol A Exposure on Pancreatic Islets of First- and Second-Generation Adult Mice Offspring.

Authors:  Amita Bansal; Cetewayo Rashid; Frances Xin; Changhong Li; Erzsebet Polyak; Anna Duemler; Tom van der Meer; Martha Stefaniak; Sana Wajid; Nicolai Doliba; Marisa S Bartolomei; Rebecca A Simmons
Journal:  Environ Health Perspect       Date:  2017-09-27       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.